{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:46:08Z","timestamp":1791963968267,"version":"4.3.4"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Thyroid carcinomas of follicular-cell origin are divided into 2 distinct morphologic and molecular families, RAS-like and BRAF p.V600E-like. Multifocality is common, usually of a single type. We retrospectively examined thyroid specimens diagnosed between 2019 and 2025 at one institution to evaluate the prevalence, clinicopathologic features, and immunohistochemical profiles of multifocal thyroid carcinomas with discordant molecular drivers. Clinical, demographic, and pathologic data were collected. Tissue microarrays were constructed for immunohistochemistry to localize BRAF p.V600E, NRAS p.Q61R, HBME-1, CK19, and Galectin-3. Among 1778 thyroid specimens, 626 thyroidectomy cases contained follicular cell-derived carcinomas. Multifocal disease was identified in 245 patients (39.1%); 63 (25.7%) had coexisting RAS-like and BRAF p.V600E-like carcinomas within the same gland. Most cases had a dominant tumor &gt;1\u00a0cm and a second tumor &lt;1\u00a0cm; in 19 cases (7.8%), both tumors were \u22651\u00a0cm. RAS-like tumors were larger (mean 3.6\u00a0cm) than BRAF p.V600E-like tumors (mean 1.85\u00a0cm; median 2.30 vs. 0.60\u00a0cm,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). HBME-1, CK19 and galectin-3 expression was more frequent in BRAF p.V600E-like tumors (81.0%, 82.5%, and 74.6%) compared with RAS-like tumors (63.5%, 65.1%, and 28.6%) (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.004,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.003 and\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001). Lymphatic invasion occurred in 14 cases and lymph node metastasis in 10, predominantly from BRAF p.V600E-like papillary thyroid carcinoma, including 9 metastases arising from the smaller tumor focus. Two collision tumors were identified. We conclude that RAS-like and BRAF p.V600E-like tumors commonly coexist within the same thyroid gland. BRAF p.V600E-like papillary thyroid carcinomas demonstrate greater metastatic potential regardless of size, highlighting the importance of comprehensive histopathologic, immunohistochemical, and molecular evaluation for accurate risk stratification and individualized management.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002594","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:00:17Z","timestamp":1785319217000},"page":"1324-1332","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Multifocal Thyroid Follicular Cell-Derived Carcinomas With Discordant Molecular Drivers"],"prefix":"10.1097","volume":"50","author":[{"given":"Eren","family":"Altun","sequence":"first","affiliation":[{"name":"Department of Pathology, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH"},{"name":"Department of Pathology, University of Health Sciences, Istanbul Bagcilar Training and Research Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammer","family":"Ergen\u00e7","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Marmara University School of Medicine, Istanbul, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Western Reserve University, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"R1-20261014","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"R2-20261014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2014.0540","article-title":"Implications of the TCGA genomic characterization of papillary thyroid carcinoma for thyroid pathology: does follicular variant papillary thyroid carcinoma exist?","volume":"25","author":"Asa","year":"2015","journal-title":"Thyroid"},{"key":"R3-20261014","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/path.6456","article-title":"Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer","volume":"267","author":"Asa","year":"2025","journal-title":"J Pathol"},{"key":"R4-20261014","first-page":"27","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"EndocrPathol"},{"key":"R5-20261014","first-page":"112","article-title":"The presence of Typical \u201cBRAFV600E-Like\u201d atypia in papillary thyroid carcinoma is highly specific for the presence of the BRAFV600E mutation","volume":"34","author":"Turchini","year":"2023","journal-title":"EndocrPathol"},{"key":"R6-20261014","first-page":"4116","article-title":"Distinct multiple ret\/PTC gene rearrangements in multifocal papillary thyroid neoplasia","volume":"83","author":"Sugg","year":"1998","journal-title":"JClinEndocrinolMetab"},{"key":"R7-20261014","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa044190","article-title":"Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma","volume":"352","author":"Shattuck","year":"2005","journal-title":"NEnglJMed"},{"key":"R8-20261014","first-page":"1586","article-title":"Molecular and histopathologic characteristics of multifocal papillary thyroid carcinoma","volume":"37","author":"Bansal","year":"2013","journal-title":"AmJ SurgPathol"},{"key":"R9-20261014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.4696","article-title":"Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles","volume":"239","author":"Lu","year":"2016","journal-title":"J Pathol"},{"key":"R10-20261014","first-page":"1359","article-title":"Multifocal papillary thyroid carcinomas with discordant molecular drivers: emphasizing the morphology and collision tumors","volume":"48","author":"Rivera","year":"2024","journal-title":"AmJ SurgPathol"},{"key":"R11-20261014","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/10507256251363120","article-title":"American Thyroid Association Management Guidelines for adult patients with differentiated thyroid cancer","volume":"35","author":"Ringel","year":"2025","journal-title":"Thyroid"},{"key":"R12-20261014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R13-20261014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00423-013-1145-7","article-title":"Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES)","volume":"399","author":"Iacobone","year":"2014","journal-title":"Langenbecks ArchSurg"},{"key":"R14-20261014","first-page":"8","article-title":"Next-generation immunohistochemistry in thyroid neoplasm: a practical review on the applications in diagnosis and molecular classification","volume":"36","author":"Rivera","year":"2025","journal-title":"EndocrPathol"},{"key":"R15-20261014","article-title":"Protocol for the examination of specimens from patients with carcinomas of the thyroid gland","author":"Mete","year":"2023","journal-title":"Coll Am Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:00:18Z","timestamp":1791961218000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002594"}},"subtitle":["Morphologic and Clinical Features in 63 Patients"],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002594","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}